<DOC>
	<DOCNO>NCT00018889</DOCNO>
	<brief_summary>The goal protocol identify family inherit movement disorder evaluate disease manifestation establish accurate clinical diagnosis use new technological advance investigate underlying molecular mechanism . Studies inherit movement disorder large family good genealogical record especially valuable . Patients diseases known molecular basis genotyped order investigate phenotype/genotype correlation . Patients disease unknown incomplete genetic characterization study hope contribute identification specific disease-causing gene genetic mechanism responsible specific disorder .</brief_summary>
	<brief_title>Phenotype/Genotype Correlations Movement Disorders</brief_title>
	<detailed_description>Objective : The goal protocol identify family inherit movement disorder evaluate disease manifestation establish accurate clinical diagnosis , investigate underlying molecular mechanism . Studies inherit movement disorder large family good genealogical record especially valuable . Additionally , plan screen subject without Parkinson 's disease presence revelant antibody , antibody target tobacco mosaic virus antigen may protective role development disease may relate pathophysiologic mechanism . We also assess series exploratory peripheral blood biomarkers , include , limited , delineated DNA , RNA , protein , and/or metabolite alteration effort accurately predict , risk , specific neurological disease . Finally , seek validate NIH Toolbox Odor Identification Test ( NIHOIT ) standard University Pennsylvania Smell Identification Test ( UPSIT ) patient Parkinson 's Disease . Study population : Subjects older 2 year old movement disorder family member enrol . Patients diseases known molecular basis genotyped order investigate phenotype/genotype correlation . Patients disease unknown incomplete genetic characterization study hope contribute identification specific disease cause gene genetic mechanism and/or peripheral biosignatures involve particular disorder . Design : Eligible participant initial medical and/or neurological evaluation Clinical Center field , include blood draw genetic biomarker test . Outcome measure : Determination phenotype/genotype correlation specific movement disorder , gene identification know , gene expression protein metabolite level , presence antibody Parkinson 's disease establishment clinical diagnosis possible .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : Individuals know suspect inherited movement disorder . Family member movement disorder patient EXCLUSION CRITERIA : Pregnant woman exclude MRI Xray study Children le 2 year age Those provide consent appoint Durable Power Attorney ( DPA )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 6, 2017</verification_date>
	<keyword>Clinical Evaluation</keyword>
	<keyword>Genetic Study</keyword>
	<keyword>Essential Tremor</keyword>
	<keyword>Familial Myoclonus</keyword>
	<keyword>Hereditary Ataxia</keyword>
	<keyword>Movement Disorder</keyword>
	<keyword>Inherited Movement Disorder</keyword>
</DOC>